Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-043011

Director sold 2,000 shares at an average $43.85 ($87,690)

  • Director acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HERSHBERG ROBERT Director 2020-07-15 Option exercise +2,000 $0.45 $900 2,000 D: show line 1 in the form
HERSHBERG ROBERT Director 2020-07-15 Sale −1,500 $43.60 $65,400 500 D: show line 2 in the form
HERSHBERG ROBERT Director 2020-07-15 Sale −500 $44.58 $22,290 0 D: show line 3 in the form
Open-market sales · 2,000 sh · avg $43.85 · $87,690

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
HERSHBERG ROBERT Director 2020-07-15 Option exercise · Stock Option (Right to Buy) −2,000 69,000 D: show line 4 in the form
Loading xslF345X03/doc4.xml…